These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15639076)

  • 1. A scanning electron microscopic study of the contraceptive vaginal ring.
    Miller L; MacFarlane SA; Materi HL
    Contraception; 2005 Jan; 71(1):65-7. PubMed ID: 15639076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can Lactobacillus acidophilus influence the adhesion capacity of Candida albicans on the combined contraceptive vaginal ring?
    Chassot F; Camacho DP; Patussi EV; Donatti L; Svidzinski TI; Consolaro ME
    Contraception; 2010 Apr; 81(4):331-5. PubMed ID: 20227551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaginal yeast adherence to the combined contraceptive vaginal ring (CCVR).
    Camacho DP; Consolaro ME; Patussi EV; Donatti L; Gasparetto A; Svidzinski TI
    Contraception; 2007 Dec; 76(6):439-43. PubMed ID: 18061701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical acceptability of an ethylene-vinyl-acetate nonmedicated vaginal ring.
    Roumen FJ; Dieben TO
    Contraception; 1999 Jan; 59(1):59-62. PubMed ID: 10342086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steroidal contraceptive vaginal rings.
    Sarkar NN
    Int J Clin Pract; 2003 Jun; 57(5):392-5. PubMed ID: 12846344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of vaginal dysbiosis and biofilm with contraceptive vaginal ring biomass in African women.
    Hardy L; Jespers V; De Baetselier I; Buyze J; Mwambarangwe L; Musengamana V; van de Wijgert J; Crucitti T
    PLoS One; 2017; 12(6):e0178324. PubMed ID: 28594946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface roughness of different contraceptive vaginal rings: evaluation by scanning electron microscope (SEM).
    Grandi G; Timò A; Sammarini M; Del Savio MC; Facchinetti F
    Eur J Contracept Reprod Health Care; 2020 Feb; 25(1):60-64. PubMed ID: 31922428
    [No Abstract]   [Full Text] [Related]  

  • 8. Contraceptive vaginal ring.
    Madden T; Blumenthal P
    Clin Obstet Gynecol; 2007 Dec; 50(4):878-85. PubMed ID: 17982330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical performance and menstrual bleeding patterns with three dosage combinations of a Nestorone progestogen/ethinyl estradiol contraceptive vaginal ring used on a bleeding-signaled regimen.
    Weisberg E; Brache V; Alvarez F; Massai R; Mishell DR; Apter D; Gale J; Sivin I; Tsong YY; Fraser IS
    Contraception; 2005 Jul; 72(1):46-52. PubMed ID: 15964292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison between the vaginal ring and oral contraceptives.
    Veres S; Miller L; Burington B
    Obstet Gynecol; 2004 Sep; 104(3):555-63. PubMed ID: 15339769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delivery of microbicides to the vagina: difficulties reported with the use of three devices, adherence to use and preferences.
    Hardy E; Hebling EM; Sousa MH; Almeida AF; Amaral E
    Contraception; 2007 Aug; 76(2):126-31. PubMed ID: 17656182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contraceptive vaginal rings releasing Nestorone and ethinylestradiol: a 1-year dose-finding trial.
    Sivin I; Mishell DR; Alvarez F; Brache V; Elomaa K; Lähteenmäki P; Massai R; Miranda P; Croxatto H; Dean C; Small M; Nash H; Jackanicz TM
    Contraception; 2005 Feb; 71(2):122-9. PubMed ID: 15707562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bleeding patterns after immediate initiation of an oral compared with a vaginal hormonal contraceptive.
    Westhoff C; Osborne LM; Schafer JE; Morroni C
    Obstet Gynecol; 2005 Jul; 106(1):89-96. PubMed ID: 15994622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The contraceptive vaginal ring: female adolescents' knowledge, attitudes and plans for use.
    Carey AS; Chiappetta L; Tremont K; Murray PJ; Gold MA
    Contraception; 2007 Dec; 76(6):444-50. PubMed ID: 18061702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with willingness to use the contraceptive vaginal ring.
    Gilliam M; Holmquist S; Berlin A
    Contraception; 2007 Jul; 76(1):30-4. PubMed ID: 17586133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaginal health in contraceptive vaginal ring users - A review.
    Lete I; Cuesta MC; Marín JM; Guerra S
    Eur J Contracept Reprod Health Care; 2013 Aug; 18(4):234-41. PubMed ID: 23790132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Notifications to the Netherlands Pharmacovigilance Foundation Lareb of the expulsion of a vaginal contraceptive ring (NuvaRing) and of pregnancy during the use of it].
    Passier JL; van Puijenbroek EP; van Grootheest AC
    Ned Tijdschr Geneeskd; 2004 Oct; 148(41):2033-5. PubMed ID: 15554002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The combined contraceptive vaginal device (NuvaRing): a comprehensive review.
    Sarkar NN
    Eur J Contracept Reprod Health Care; 2005 Jun; 10(2):73-8. PubMed ID: 16147810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended regimens of the contraceptive vaginal ring: a randomized trial.
    Miller L; Verhoeven CH; Hout Ji
    Obstet Gynecol; 2005 Sep; 106(3):473-82. PubMed ID: 16135576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Nestorone and ethinyl estradiol levels, and ovulation inhibition in women using three different dosage combinations of a Nestorone progestogen-ethinyl estradiol contraceptive vaginal ring on a bleeding-signaled regimen.
    Fraser IS; Weisberg E; Brache V; Alvarez F; Massai R; Mishell DR; Apter D; Gale J; Tsong YY; Sivin I
    Contraception; 2005 Jul; 72(1):40-5. PubMed ID: 15964291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.